Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Catalent, Inc.
  6. Summary
    CTLT   US1488061029

CATALENT, INC.

(CTLT)
  Report
Delayed Quote. Delayed Nyse - 10/22 04:10:00 pm
132.73 USD   +0.32%
10/20CATALENT, INC. : Announces First Quarter Fiscal Year 2022 Earnings Conference Webcast
BU
10/18INSIDER SELL : Catalent
MT
10/06INSIDER SELL : Catalent
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
130.4(c) 133.22(c) 131.78(c) 132.31(c) 132.73(c) Last
788 593 607 155 776 555 879 620 487 137 Volume
+1.27% +2.16% -1.08% +0.40% +0.32% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 4 508 M - -
Net income 2022 487 M - -
Net Debt 2022 2 374 M - -
P/E ratio 2022 49,5x
Yield 2022 -
Sales 2023 4 913 M - -
Net income 2023 570 M - -
Net Debt 2023 1 795 M - -
P/E ratio 2023 42,6x
Yield 2023 -
Capitalization 22 678 M 22 678 M -
EV / Sales 2022 5,56x
EV / Sales 2023 4,98x
Nbr of Employees 17 300
Free-Float 99,7%
More Financials
Company
Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for... 
Sector
Pharmaceuticals
Calendar
10/28
More about the company
Ratings of Catalent, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about CATALENT, INC.
10/20CATALENT, INC. : Announces First Quarter Fiscal Year 2022 Earnings Conference Webcast
BU
10/18INSIDER SELL : Catalent
MT
10/06INSIDER SELL : Catalent
MT
10/04CATALENT : Opens New Full-Service Clinical Supply Facility in Shiga, Japan
PU
09/29CATALENT : Notes Offering (Form 8-K)
PU
09/29CATALENT, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financia..
AQ
09/24CATALENT : Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Du..
PU
09/24CATALENT : Prices Upsized Offering of $650 Million Senior Notes
MT
09/23CATALENT : Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Du..
BU
09/23CATALENT : Subsidiary to Launch $450 Million Notes Offering
MT
09/23CATALENT : Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes ..
PU
09/23CATALENT, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/23CATALENT : Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes ..
BU
09/16CATALENT : Signs Commercial Supply Agreement with Phathom Pharmaceuticals
PU
09/09Catalent to Seek Acquisitions
CI
More news
News in other languages on CATALENT, INC.
10/18PFIZER/BIONTECH : ok Ema a 2 siti produttivi e nuova formulazione vaccino
10/06VENTE D'INITIÉS : Catalent
09/24Catalent propose une offre élargie de 650 millions de dollars d'obligations de premier ..
08/30MÄRKTE USA/Käufe in Technologiewerten sorgen für Rekorde
08/30MÄRKTE USA/Wall Street legt im Verlauf weiter zu
More news
Analyst Recommendations on CATALENT, INC.
More recommendations
Stock Trading Strategies
CATALENT, INC. - 2020
The trend should continue
BUY
More Stock Trading Analysis
Chart CATALENT, INC.
Duration : Period :
Catalent, Inc. Technical Analysis Chart | CTLT | US1488061029 | MarketScreener
Technical analysis trends CATALENT, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 132,73 $
Average target price 153,90 $
Spread / Average Target 15,9%
EPS Revisions
Managers and Directors
John R. Chiminski Chairman & Chief Executive Officer
Alessandro Maselli President & Chief Operating Officer
Thomas P. Castellano Chief Financial Officer & Senior Vice President
Kay Schmidt Senior Vice President-Technical Operations
Julien Meissonnier Chief Scientific Officer & Vice President
Sector and Competitors
1st jan.Capi. (M$)
CATALENT, INC.27.54%22 678
JOHNSON & JOHNSON4.03%430 990
ROCHE HOLDING AG15.15%337 974
NOVO NORDISK A/S58.77%242 392
PFIZER, INC.16.44%241 985
ELI LILLY AND COMPANY44.37%220 979